News
Biocon is set to launch generic versions of Wegovy in India and Canada, aiming for market entry by late 2026 or early 2027.
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
4h
Korea JoongAng Daily on MSNBiocon eyes generic Wegovy launch in India, Canada in next 2 years, CEO saysBiocon plans to launch generic copies of Wegovy in India and Canada within two years, targeting a growing drug market ...
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...
Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...
Eli Lilly's weight loss drugs, especially Zepbound and Mounjaro, have driven impressive revenue growth. Click here to read an ...
TikToker Insightful Lucy has revealed the four things she wished she had known before starting Mounjaro, after losing six stone on the medication.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results